CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease
2021; American Association for the Advancement of Science; Volume: 13; Issue: 613 Linguagem: Inglês
10.1126/scitranslmed.abe7104
ISSN1946-6242
AutoresSara Picó, Alberto Parras, María Santos‐Galindo, Julia Pose‐Utrilla, Margarita Castro, Enrique Fraga, Ivó H. Hernández, Ainara Elorza, Héctor Anta, Nan Wang, Laura Martí‐Sánchez, Eulàlia Belloc, Paula Garcia‐Esparcia, Juan José Garrido, Isidró Ferrer, Daniel Macías‐García, Pablo Mir, Rafael Artuch, Belén Pérez, Félix Hernández, Pilar Navarro, José Luis López-Sendón, Teresa Iglesias, Xia Yang, Raúl Méndez, José J. Lucas,
Tópico(s)Parkinson's Disease Mechanisms and Treatments
ResumoAltered CPEBs and mRNA polyadenylation lead to thiamine deficiency in the brains of patients and mice with Huntington’s disease.
Referência(s)